Asset
ROXADUSTAT
Revenue
No revenue reported in loaded filings.
Clinical trials (22)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01750190 | phase3 | completed | 2012-11-05 | 2018-09-24 | Kyntra Bio | A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis |
| NCT05301517 | phase3 | completed | 2022-03-16 | 2023-04-03 | Kyntra Bio | A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies |
| NCT07722988 | phase3 | not_yet_recruiting | 2027-04-01 | 2030-09-01 | Kyntra Bio | A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS) |
| NCT03303066 | phase2_3 | completed | 2018-06-06 | 2023-01-11 | Kyntra Bio | Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS) |
| NCT03263091 | phase3 | terminated | 2018-01-29 | 2023-03-09 | Kyntra Bio | Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden |
FDA applications (0)
This company has no applications containing this asset.